FEBRUARY 18, 2012

European Urology - Phosphodiesterase Type 5 Inhibitors: The Day After

E-mail Print
Volume 51, Issue 1, Pages 75-89 (January 2007)

Abstract -

Objective:

Review the literature on phosphodiesterase type 5 inhibitors (PDE5-Is), addressing critical issues in their current and future use, assessing unanswered questions, and identifying research needs.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |